Liberia

in page functions
Total population (2013) 4,294,077
Birth cohort (2013) 152,031
Surviving Infants (surviving to 1 year per year, 2013) 142,948
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 56/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 75/1000
World Bank Index, IDA (2012) 2.92
Gross Nation Income (per capita US$, 2012) 370
Co-financing status (2013) Low-income
No. of districts/territories (2012) 15

GAVI support for Liberia

Type of support

Approvals

2001-2017 (US$)
(31 Dec 2013)

Commitments

2001-2017 (US$)
(31 Dec 2013)

Disbursements

2000-2013 (US$)
(31 Dec 2013)

% Disbursed

(31 Dec 2013)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Health system strengthening (HSS) $7,330,000 $8,770,000 $4,090,000 56%
Immunisation services support (ISS) $2,188,750 $2,188,750 $2,188,750 100%
Injection safety support (INS) $360,500 $360,500 $266,500 74%
Penta (NVS) $9,126,127 $10,066,627 $8,727,404 96%
Pneumo (NVS) $2,988,500 $5,562,500 $3,683,119 123%
Vaccine Introduction Grant $355,000 $355,000 $355,000 100%
Yellow Fever (NVS) $1,550,308 $1,777,308 $1,416,137 91%
Total $23,899,185 $29,080,685 $20,726,910

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Liberia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2012)

Grade of confidence
77%

*
DTP3 - Official country estimates (2012) 93%
M:F sex ratio at birth (2013) 1.05
Household survey: DTP3 coverage for male (2007) 49.00%
Household survey: DTP3 coverage for female (2007) 51.60%
Household survey: Last DTP3 survey (2007) 50%
% districts achieving > 80% DTP3 coverage (2012) 93%
% districts achieving < 50% DTP3 coverage (2012) 0%
MCV WHO/UNICEF estimates (2012) 80%
Polio WHO/UNICEF estimates (2012) 77%

Breakdown of support

Non-vaccine support Vaccine support
33% 67%
$6,900,250 $13,826,660

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Liberia

04 February 2014

HPV vaccine with GAVI support

206,000 more girls to benefit from HPV vaccine with GAVI Alliance support

10 countries approved in latest round of HPV vaccine demonstration programmes.

10 January 2014

Liberia pneumococcal launch thumb

Liberia begins protecting its children against pneumococcal disease

President Ellen Johnson Sirleaf joins celebrations in Monrovia.

07 August 2013

Sabin Institute

At Dakar conference, countries showcase increased efforts to fund their own immunisation programs

Sabin Vaccine Institute convenes government officials to discuss progress on sustainable immunization financing programs (News release: Sabin Vaccine Institute).

close icon

modal window here